(3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl dihydrogen phosphate,
1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-,
BMS-663068,
fostemsavir,
Fostemsavir,
864953-29-7,
BMS-663068,
Fostemsavir(BMS-663068),
BMS-663068 free acid,
BMS 663068,
UNII-97IQ273H4L,
Fostemsavir [USAN],
97IQ273H4L,
Fostemsavir (USAN),
BMS663068,
SCHEMBL754395,
Fostemsavir; BMS-663068,
CHEMBL3301594,
C25H26N7O8P,
DTXSID40235596,
BCP13226,
EX-A1973,
3502AH,
HY-15440A,
ZINC14210883,
BMS-663038,
CS-1059,
DB11796,
SB11250,
[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate,
BC600763,
Piperazine, 1-benzoyl-4-((4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)oxoacetyl)-,
A15025,
D10707,
W-5998,
({3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl}methoxy)phosphonic acid,
1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-,
CID11319217,
CID 11319217,